Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06526195 · ClinicalTrials.gov registry record · NA

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

A NA study of Heart Failure and Cardiovascular Diseases, sponsored by Abbott Medical Devices.

Recruiting
Registry status
NA
Development phase
850
Enrollment target
20
Study locations

NCT06526195 is a NA study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 850 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06526195, a NA study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by Abbott Medical Devices.

RECRUITING
Registry status
NA
Development phase
850 participants
Enrollment target
20
Study locations

Study Summary

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

Conditions Studied

Heart Failure Cardiovascular Diseases Heart Diseases Pulmonary Hypertension

Interventions

  • DEVICE CardioMEMS HF System
  • DEVICE HeartMate 3 Left Ventricular Assist System
  • OTHER Guideline Medical Directed Therapy

Study Locations (20)

Georgia

  • Piedmont Heart Institute - Atlanta
  • Piedmont Augusta Hospital - Augusta
  • WellStar Kennestone Hospital - Marietta

California

  • Sutter Medical Center - Sacramento
  • University of California at San Francisco - San Francisco

Florida

  • Shands at the University of Florida - Gainesville
  • Cleveland Clinic Florida - Weston

Kentucky

  • University of Kentucky - Lexington
  • Norton Hospital - Louisville

Michigan

  • Henry Ford Hospital - Detroit
  • Spectrum Health Butterworth Hospital - Grand Rapids

Arizona

  • Banner-University Medical Center Phoenix - Phoenix

Arkansas

  • Baptist Health Medical Center - Little Rock

District of Columbia

  • Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 850 participants
Start Date 2024-12-13
Est. Completion 2032-09
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06526195

The ClinicalTrials.gov registry entry for NCT06526195 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 850 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which CardioMEMS HF System is the first listed.

NCT06526195 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Georgia, California, Florida.

Frequently Asked Questions

What is clinical trial NCT06526195 about?

NCT06526195 is a clinical study titled "Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure". The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

What is the current status of trial NCT06526195?

This trial is currently recruiting. It is a NA study. The enrollment target is 850 participants. The study started on 2024-12-13. Estimated completion is 2032-09.

What conditions does trial NCT06526195 study?

This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases, Heart Diseases, Pulmonary Hypertension.

What interventions are being tested in trial NCT06526195?

The interventions under investigation include: CardioMEMS HF System (DEVICE), HeartMate 3 Left Ventricular Assist System (DEVICE), Guideline Medical Directed Therapy (OTHER).

Who is sponsoring clinical trial NCT06526195?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06526195 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Cardiovascular Diseases

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.